×

,2015

Aberrant expression of COT is related to recurrence of papillary thyroid cancer
MEDICINE 94/6 :0-0,2015

KSR1 is coordinately regulated with notch signaling and oxidative phosphorylation in thyroid cancer
JOURNAL OF MOLECULAR ENDOCRINOLOGY 54/2 :115-124,2015

Extracapsular en bloc resection in pituitary adenoma surgery
PITUITARY 18/3 :397-404,2015

GLI1 Transcription Factor Affects Tumor Aggressiveness in Patients With Papillary Thyroid Cancers
MEDICINE 94/25 :e998-,2015

Association Between Obesity and BRAFV600E Mutation Status in Patients with Papillary Thyroid Cancer
ANNALS OF SURGICAL ONCOLOGY 22/Suppl :683-690,2015

Olfactory receptor Olfr544 responding to azelaic acid regulates glucagon secretion in α-cells of mouse pancreatic islets.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 460/3 :616-621,2015

Distinct Features of Nonthyroidal Illness in Critically Ill Patients With Infectious Diseases
MEDICINE 95/14 :e3346-,2016

No differences in metabolic outcomes between nadir GH 0.4 and 1.0 ng/mL during OGTT in surgically cured acromegalic patients (observational study)
MEDICINE 95/24 :e3,808-,2016

The Effects of High Fat Diet and Resveratrol on Mitochondrial Activity of Brown Adipocytes
대한내분비학회지 31/2 :328-335,2016

Intestinal Glycolysis Visualized by FDG PET/CT Correlates With Glucose Decrement After Gastrectomy
DIABETES 66/2 :385-391,2017

Increased miR-338-3p expression correlates with invasiveness of GH-producing pituitary adenomas
ENDOCRINE 58/1 :184-189,2017

Postoperative Gamma Knife radiosurgery for cavernous sinus-invading growth hormone-secreting pituitary adenomas
WORLD NEUROSURGERY 110/ :534-545,2018

Olfactory marker protein regulates prolactin secretion and production by modulating Ca2+ and TRH signaling in lactotrophs
EXPERIMENTAL AND MOLECULAR MEDICINE 50/4 :15-25,2018

A selective cyclin-dependent kinase 4, 6 dual inhibitor, Ribociclib (LEE011) inhibits cell proliferation and induces apoptosis in aggressive thyroid cancer
CANCER LETTERS 417/ :131-140,2018

Age- and Sex-Specific Differences as Predictors of Surgical Remission Among Patients With Acromegaly
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 103/3 :909-916,2018

Comparative assessment of Graves' disease and main extrathyroidal manifestation, Graves' ophthalmopathy, by non-targeted metabolite profiling of blood and orbital tissue
SCIENTIFIC REPORTS 8/1 :9,262-9,273,2018

Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas.
WORLD NEUROSURGERY 115/ :e464-e471,2018

Long-acting FC-fusion rhGH (GX-H9) shows potential for up to twice-monthly administration in GH-deficient adults
EUROPEAN JOURNAL OF ENDOCRINOLOGY 179/3 :169-179,2018

Lipidomic differentiation of Graves’ ophthalmopathy in plasma and urine from Graves’ disease patients
ANALYTICAL AND BIOANALYTICAL CHEMISTRY 410/27 :7121-7133,2018

Outcomes of Aggressive Surgical Resection in Growth Hormone-Secreting Pituitary Adenomas with Cavernous Sinus Invasion
WORLD NEUROSURGERY 117/ :280-289,2018

Changes of computed tomography-based body composition after adrenalectomy in patients with endogenous hypercortisolism
CLINICAL ENDOCRINOLOGY 90/2 :267-276,2019

Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
Endocrinology and Metabolism 34/1 :53-62,2019

Prevalence of Thyroid Disease in Patients Surgically Treated for Pituitary Disease
Journal of Clinical Medicine 8/8 :E1142-,2019

Clinical Significance of Radical Surgery in the Treatment of Silent Corticotroph Adenoma
JOURNAL OF KOREAN NEUROSURGICAL SOCIETY 62/1 :114-122,2019